Foster & Motley’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.17M Sell
84,696
-135
-0.2% -$10.9K 0.33% 76
2026
Q1
$6M Buy
84,831
+3,939
+5% +$295K 0.31% 88
2025
Q4
$6.39M Buy
80,892
+3,956
+5% +$313K 0.34% 79
2025
Q3
$6.34M Buy
76,936
+4,343
+6% +$342K 0.34% 76
2025
Q2
$5.84M Buy
72,593
+7,985
+12% +$616K 0.34% 80
2025
Q1
$5.19M Buy
64,608
+6,056
+10% +$504K 0.33% 81
2024
Q4
$4.79M Sell
58,552
-6,662
-10% -$554K 0.31% 83
2024
Q3
$5.38M Sell
65,214
-8,942
-12% -$668K 0.34% 81
2024
Q2
$5.21M Sell
74,156
-2,412
-3% -$172K 0.36% 73
2024
Q1
$5.67M Sell
76,568
-7,701
-9% -$537K 0.39% 67
2023
Q4
$5.57M Sell
84,269
-2,921
-3% -$183K 0.41% 63
2023
Q3
$5.49M Sell
87,190
-3,082
-3% -$192K 0.45% 55
2023
Q2
$5.1M Sell
90,272
-2,770
-3% -$154K 0.4% 66
2023
Q1
$5.39M Buy
93,042
+384
+0.4% +$25.9K 0.44% 58
2022
Q4
$6.71M Buy
92,658
+6,135
+7% +$439K 0.57% 42
2022
Q3
$5.26M Buy
86,523
+15,454
+22% +$987K 0.5% 47
2022
Q2
$4.46M Buy
71,069
+11,041
+18% +$731K 0.39% 60
2022
Q1
$4.22M Buy
60,028
+1,746
+3% +$118K 0.33% 73
2021
Q4
$3.64M Buy
58,282
+3,259
+6% +$205K 0.28% 92
2021
Q3
$3.4M Buy
55,023
+8,311
+18% +$500K 0.28% 91
2021
Q2
$2.8M Buy
46,712
+752
+2% +$47.7K 0.23% 113
2021
Q1
$2.79M Sell
45,960
-2,400
-5% -$132K 0.23% 109
2020
Q4
$2.27M Sell
48,360
-1,458
-3% -$63.2K 0.22% 111
2020
Q3
$1.85M Buy
49,818
+21,637
+77% +$821K 0.22% 111
2020
Q2
$1.03M Sell
28,181
-1,938
-6% -$67.5K 0.13% 141
2020
Q1
$921K Sell
30,119
-2,406
-7% -$107K 0.14% 138
2019
Q4
$1.66M Buy
32,525
+125
+0.4% +$6.03K 0.21% 118
2019
Q3
$1.53M Sell
32,400
-277
-0.8% -$13.2K 0.21% 117
2019
Q2
$1.62M Sell
32,677
-686
-2% -$32.2K 0.23% 107
2019
Q1
$1.42M Buy
33,363
+4,892
+17% +$216K 0.2% 115
2018
Q4
$1.17M Buy
28,471
+23,913
+525% +$1.03M 0.19% 116
2018
Q3
$213K Buy
+4,558
New +$208K 0.03% 230
2018
Q2
Sell
-4,558
Closed -$209K 241
2018
Q1
$209K Sell
4,558
-450
-9% -$21.8K 0.03% 215
2017
Q4
$253K Sell
5,008
-562
-10% -$29.6K 0.04% 203
2017
Q3
$289K Sell
5,570
-1,297
-19% -$63.2K 0.05% 180
2017
Q2
$336K Sell
6,867
-667
-9% -$30.9K 0.06% 159
2017
Q1
$355K Sell
7,534
-2,020
-21% -$96.3K 0.06% 151
2016
Q4
$459K Sell
9,554
-4,895
-34% -$225K 0.09% 137
2016
Q3
$572K Sell
14,449
-3,635
-20% -$137K 0.11% 128
2016
Q2
$642K Buy
18,084
+3,448
+24% +$134K 0.13% 119
2016
Q1
$573K Sell
14,636
-1,632
-10% -$61K 0.12% 121
2015
Q4
$699K Sell
16,268
-1,984
-11% -$87.2K 0.15% 121
2015
Q3
$767K Sell
18,252
-2,016
-10% -$94.2K 0.17% 113
2015
Q2
$1.01M Buy
20,268
+1,222
+6% +$57.9K 0.22% 102
2015
Q1
$858K Buy
19,046
+2,976
+19% +$134K 0.19% 106
2014
Q4
$775K Buy
16,070
+792
+5% +$37.6K 0.18% 106
2014
Q3
$732K Sell
15,278
-1,977
-11% -$96K 0.17% 104
2014
Q2
$854K Buy
17,255
+3,286
+24% +$154K 0.2% 97
2014
Q1
$657K Buy
+13,969
New +$642K 0.16% 106

Other funds holding MET

Foster & Motley's MET Position: Q2 2026 in Review

Foster & Motley reduced its MetLife (MET) stake by 0.16% in Q2 2026, selling an estimated $10.9K and leaving 84,696 shares worth $7.17M. The position accounts for 0.33% of the portfolio, ranked #76.

Foster & Motley first reported a position in MET in Q1 2014 and has held it in 49 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Foster & Motley held 84,696 shares of MetLife worth $7.17M as of Q2 2026.
  • Foster & Motley sold 135 MetLife shares in Q2 2026, an estimated $10.9K.
  • MetLife made up 0.33% of Foster & Motley's portfolio in Q2 2026, its #76 holding.
  • Foster & Motley first reported a position in MetLife in Q1 2014 and has held it in 49 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.